ＨＢｅ抗原陰性Ｂ型慢性肝炎患者におけるラミブジン投与中止時期についての検討

DOI Web Site 被引用文献1件 参考文献1件

書誌事項

タイトル別名
  • Timing of withdrawal of lamivudine treatment for HBeAg-negative chronic hepatitis B patients

この論文をさがす

抄録

We studied the timing of withdrawal of lamivudine administration for HBe Ag-negative chronic patients. The amount of serum HBV DNA was measured using the Amplicor HBV monitor (AM) and the Real-time Detection direct (RTD-direct). All values became less than 2.6 log copies/ml according to the AM method after administration. Five of 16 patients were found to have no HBV according to the RTD-direct (less than 1.0 log copies/ml). Thus, withdrawal of administration was attempted for these five patients. After the withdrawal, the viral load and ALT levels had increased in all patients. These results showed the difficulty of withdrawing lamivudine administration from HBe Ag-negative chronic patients, even though they have very low viral load in serum by the treatment.<br>

収録刊行物

  • 肝臓

    肝臓 47 (11), 516-517, 2006

    一般社団法人　日本肝臓学会

被引用文献 (1)*注記

もっと見る

参考文献 (1)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ